Sarah Hoch, PA
Medical · Fort Collins, CONPI 1811271323
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.0%), consulting fees and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Incyte Corporation at 31.6% of the total. Among medical clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $48.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$3K
- Novartis$2K
- LEO Pharma Inc.$594
- UCB, Inc.$500
- Sun Pharmaceutical Industries Inc.$412
- Sanofi$344
- plus $2K from 18 others
What the payments were for
- Consulting fees$3,51544%
- Food & beverage$4,41555%
- Education$951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 8 | $2,534 |
| Novartis | 37 | $1,603 |
| LEO Pharma Inc. | 6 | $594 |
| UCB, Inc. | 16 | $500 |
| Sun Pharmaceutical Industries Inc. | 7 | $412 |
| Sanofi | 11 | $344 |
| Pfizer | 10 | $301 |
| Johnson & Johnson | 9 | $220 |
| AbbVie | 9 | $197 |
| Lilly USA, LLC | 8 | $188 |
| Amgen | 13 | $187 |
| Galderma Laboratories, L.p. | 4 | $139 |
| Dermavant Sciences, Inc. | 3 | $132 |
| Organon | 3 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $113 |
| E.r. Squibb & Sons, L.L.C. | 4 | $93 |
| Almirall LLC | 3 | $89 |
| Arcutis Biotherapeutics, Inc. | 4 | $65 |
| Revance Therapeutics, Inc. | 1 | $51 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $45 |
| Biofrontera Inc. | 2 | $38 |
| Journey Medical Corporation | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,025 in reported general payments places this provider in the 90th percentile of 766 medical providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 52 | $599 |
| Metronidazole | 11 | $544 |
Paid to pharmacies, not to this prescriber.
Other medical in Fort Collins
- Amanda MixonFort Collins$342K
- Michael JacobsonFort Collins$131K
- Brian CronkFort Collins$11K
- Emily BerganiniFort Collins$9K
- Gregory SimsFort Collins$8K
- Christen KutzColorado Springs$610K
- Kristin RyggColorado Springs$255K
- Jordan MastDenver$247K
- John NovakAurora$173K
- Michelle BarnettColorado Springs$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.